Clinical Trial Update: Evaluation of Emotional Disorders During Treatment by Interferon Beta in Relapsing-remitting Multiple Sclerosis Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating emotional disorders in relapsing-remitting multiple sclerosis patients treated with interferon beta; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Drugs mentioned

• Interferon-beta (interferon beta)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Multiple Sclerosis, Relapsing, Remitting | Phase 4 | Status: COMPLETED | Results posted: 2012-04-11